-- Announcement on Resignation of General Manager and Appointment of a New General Manager
Securities code: 600867 Securities abbreviation: Tonghua Dongbao Announcement number: 2025-051
Tonghua Dongbao Pharmaceutical Co., Ltd.
Announcement on the resignation of the general manager and the new general manager of the company
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
The board of directors of Tonghua Dongbao Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company" or "Tonghua Dongbao") recently received a written resignation report from the general manager Mr. Leng Chunsheng. Due to adjustments in work arrangements and based on the development needs of the joint-stock company Junhemeng Biopharmaceutical (Hangzhou) Co., Ltd., Mr. Leng Chunsheng applied to resign from the position of general manager of the company. After his resignation, Mr. Leng Chunsheng continued to serve as vice chairman of the company and served as a member of the strategy committee, remuneration and assessment committee, nomination committee and audit committee of the board of directors. At the same time, the company decided to appoint Mr. Leng Chunsheng as the company’s chief scientific advisor.
1. General manager’s resignation
(1) Basic circumstances of early resignation
Whether to continue
Does it exist on
Still unfulfilled
Original term of office: city company, specific position (if applicable, name, resignation position, time of resignation, reason for resignation, expiration date and control)
of public subsidiaries
Commitment to serve in the Department
Vice Chairman; Strategy Committee, Remuneration and Appraisal Committee of the Board of Directors
2025 8 September 2026
Leng Chunsheng General Manager Work Arrangement Adjustment Yes Committee, Nomination Committee No January 25th 7th
Member, Audit Committee; Chief Scientific Advisor
In order to promote the company's strategic arrangement and implementation, based on the development needs of the joint-stock company Junhemeng Biopharmaceutical (Hangzhou) Co., Ltd., Mr. Leng Chunsheng plans to join the joint-stock company and devote himself to the work of Junhemeng Biopharmaceutical (Hangzhou) Co., Ltd. to further focus on product development, promote the company and the joint-stock company to exert synergy more effectively, and create a more comprehensive biopharmaceutical enterprise. He specifically applies to resign from the position of general manager of Tonghua Dongbao. After his resignation, Mr. Leng Chunsheng continued to serve as Vice Chairman of Tonghua Dongbao and served as a member of the Strategy Committee, Remuneration and Assessment Committee, Nomination Committee, and Audit Committee of the Board of Directors.
At the same time, in view of Mr. Leng Chunsheng’s rich experience in the field of biopharmaceutical research and development, the company decided to appoint Mr. Leng Chunsheng as the company’s chief scientific advisor, and he will continue to serve as a leading figure in science and technology to assist the company’s research and development, technology promotion and technological innovation-related work of innovative drugs. The company will continue to enhance its innovation capabilities, promote the research and development and launch of innovative drugs, continuously improve its scientific and technological innovation system, and actively cultivate new business growth points.
(2) The impact of resignation on the company
In accordance with the relevant provisions of the Company Law, Articles of Association and laws and regulations, Mr. Leng Chunsheng’s resignation report will take effect from the date it is delivered to the company’s board of directors.
The work responsible for Mr. Leng Chunsheng has been properly handed over, and his change of position will not have an adverse impact on the company's normal operating activities.
Mr. Leng Chunsheng fulfilled his duties diligently and diligently during his tenure as the company's general manager, and played a positive role in the company's development. The company's board of directors expresses its sincere gratitude to Mr. Leng Chunsheng for his contribution to the company's development during his tenure as general manager!
2. Regarding the situation of the new general manager of the company
The company held the 16th meeting of the 11th board of directors on August 25, 2025, and reviewed and approved the "Proposal on the Appointment of the Company's General Manager" and agreed to appoint Mr. Li Jiahong as the company's general manager. The term of office shall commence from the date of review and approval by the current Board of Directors until the expiration of the term of the 11th Board of Directors.
Mr. Li Jiahong’s personal resume:
Li Jiahong, Han nationality, was born in June 1988. He holds a bachelor's degree. He graduated from the School of Business Administration in Idstein, Germany, in 2016 with a bachelor's degree. He joined Dongbao Industrial Group Co., Ltd. in February 2016 and served successively as secretary to the chairman, assistant to the chairman, deputy general manager and general manager of Dongbao Industrial Group Co., Ltd. He has been appointed as the chairman of Dongbao Industrial Group Co., Ltd. since March 2019; he has been appointed as the chairman of the company since March 2024; he is currently the chairman and general manager of the company.
Announcement is hereby made.
Board of Directors of Tonghua Dongbao Pharmaceutical Co., Ltd.
August 26, 2025